🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is conducted in Europe. The aim of this trial is to investigate ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2009-11
Trial ID
NCT01028404
Treatments Being Tested
The primary objective of this study is to investigate safety and tolerabili...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2017-05-18
Trial ID
NCT03135899
The goal of this clinical trial is to compare full dose MDMA-assisted thera...
Status
Terminated
Location
Offices of Dr. Ingrid Pacey MBBS FRCP[C]
Start Date
2014-10-14
Trial ID
NCT01958593
Treatments Being Tested
RV568 is being developed as a possible treatment of smoking related lung di...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01661244
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Quotient Sciences-Miami, Inc
Start Date
2023-06-27
Trial ID
NCT05950906
Multicenter, double-blind, randomized, placebo-controlled phase I/II study ...
Status
Recruiting
Location
Clinica Universidad de Navarra
Start Date
2020-03-11
Trial ID
NCT04163562
This study will test a study medicine called REGN20423 to see how effective...
Status
Recruiting
Location
Center for Clinical Pharmacology University Hospitals Leuven (UZ Leuven)
Start Date
2026-05-22
Trial ID
NCT07527923
This will be a FTIH study which aims to evaluate safety, tolerability, phar...
Status
Terminated
Location
GSK Investigational Site
Start Date
2021-09-20
Trial ID
NCT05044325
Treatments Being Tested
Part A: The primary objective is to evaluate the safety and tolerability of...
Status
Completed
Location
Biokinetic Europ Ltd
Start Date
2015-05
Trial ID
NCT02459262
Treatments Being Tested